Efficacy and safety of corticosteroid implant (Fluocinolone Acetonide (FAc) 0.2 μg/day, Iluvien ®) for management of Diabetic Macular Edema (DME): a real‐life study

Purpose: To evaluate the refractive results of Vivinex© toric intraocular lenses after a cataract surgery.Methods: We performed a prospective study including 50 eyes of 25 patients, who had a cataract surgery, operated by a unique surgeon, using Callisto© Zeiss with automated conjunctival recognition for the alignment of Vivinex© toric lenses (Hoya).Preoperative corneal astigmatism was evaluated using both corneal topography (OPDII, Nidek) and IOL master 700R keratometry (Carl Zeiss Meditec)).The lens power calculator was performed by the on line Toric calculator (V4 Hoya).Postoperative criteria where uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), residual subjective astigmatism and lens rotation objected with a photography (Eyesuite©, Luneau).Results: Patients mean age was 69.5 years.Lens distribution was: 45.5% of T3 models, 45.5% of T4 models, and 9% of the T5 one.Mean preoperative astigmatism was 1.53 D. Mean postoperative UCVA was 7.7/10, including all lenses.Mean BCVA was 9.8/10.A BCVA>8/10 was obtained in more than 1/3 of patients (36%).The medium residual subjective astigmatism was 0.43 D. The mean lens rotation was measured at 4.6°.Thanks to premium lenses, we are now able to perform cataract surgery as a refractive surgery.Toric Vivinex© lens recently arrived in France during 2017 summer.This lens is a new preloading monobloc hydrophobic IOL, which permits to correct corneal astigmatism from 0.75 D to 4 D. Refractive results are comparable to those obtained with other toric lenses as SN6AT (Alcon) and 709 MP (Carl Zeiss Meditec), which are already available, and recently reported by the same author.Conclusions: This preliminary study shows satisfactory refractive results and lens stability after one month.